UK markets close in 7 hours 54 minutes
  • FTSE 100

    6,882.87
    -6.25 (-0.09%)
     
  • FTSE 250

    22,154.43
    +0.88 (+0.00%)
     
  • AIM

    1,236.88
    +2.19 (+0.18%)
     
  • GBP/EUR

    1.1560
    +0.0029 (+0.25%)
     
  • GBP/USD

    1.3764
    +0.0022 (+0.16%)
     
  • BTC-GBP

    44,251.02
    +155.42 (+0.35%)
     
  • CMC Crypto 200

    1,296.02
    +1.44 (+0.11%)
     
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • DOW

    33,745.40
    -55.20 (-0.16%)
     
  • CRUDE OIL

    59.98
    +0.28 (+0.47%)
     
  • GOLD FUTURES

    1,725.10
    -7.60 (-0.44%)
     
  • NIKKEI 225

    29,751.61
    +212.88 (+0.72%)
     
  • HANG SENG

    28,490.06
    +36.78 (+0.13%)
     
  • DAX

    15,241.22
    +26.22 (+0.17%)
     
  • CAC 40

    6,175.66
    +13.98 (+0.23%)
     

Monoclonal Antibodies Market Research Report by Source Type, by Production Type, by Indication, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5-min read

Monoclonal Antibodies Market Research Report by Source Type (Chimeric, Human, Humanized, and Murine), by Production Type (In Vitro and In Vivo), by Indication, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, April 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Monoclonal Antibodies Market Research Report by Source Type, by Production Type, by Indication, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06045511/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Monoclonal Antibodies Market is expected to grow from USD 89,652.58 Million in 2020 to USD 153,693.39 Million by the end of 2025.
2. The Global Monoclonal Antibodies Market is expected to grow from EUR 78,609.08 Million in 2020 to EUR 134,761.28 Million by the end of 2025.
3. The Global Monoclonal Antibodies Market is expected to grow from GBP 69,883.64 Million in 2020 to GBP 119,803.07 Million by the end of 2025.
4. The Global Monoclonal Antibodies Market is expected to grow from JPY 9,568,202.08 Million in 2020 to JPY 16,402,979.30 Million by the end of 2025.
5. The Global Monoclonal Antibodies Market is expected to grow from AUD 130,187.46 Million in 2020 to AUD 223,183.24 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Monoclonal Antibodies to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Source Type, the Monoclonal Antibodies Market studied across Chimeric, Human, Humanized, and Murine.

Based on Production Type, the Monoclonal Antibodies Market studied across In Vitro and In Vivo.

Based on Indication, the Monoclonal Antibodies Market studied across Autoimmune Diseases, Cancer, Infectious Diseases, Inflammatory Diseases, and Microbial Diseases.

Based on End-User, the Monoclonal Antibodies Market studied across Hospitals and Research Institutes.

Based on Geography, the Monoclonal Antibodies Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Monoclonal Antibodies Market including Abbott Laboratories, AbbVie, Inc, AbGenomics, ADC Therapeutics, ALMAC Group, Amgen Inc., Astellas Pharma Inc, AstraZeneca PLC, Bayer AG, Biogen Idec Inc., Bristol Myers Squibb, Daiichi Sankyo Company, Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V., Novartis International AG, Novo Nordisk A/S, Pfizer Inc, Sanofi S.A., Seagen Inc., Shanghai Junshi Biosciences Co., Ltd., and Thermo Fisher Scientific, Inc.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Monoclonal Antibodies Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Monoclonal Antibodies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Monoclonal Antibodies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Monoclonal Antibodies Market?
4. What is the competitive strategic window for opportunities in the Global Monoclonal Antibodies Market?
5. What are the technology trends and regulatory frameworks in the Global Monoclonal Antibodies Market?
6. What are the modes and strategic moves considered suitable for entering the Global Monoclonal Antibodies Market?
Read the full report: https://www.reportlinker.com/p06045511/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001